PRECISION MEDICINE TECHNOLOGIES
As of 2019
- Digital biomarkers for precision medicine (DBM4PM)
- Multi-parameter core technologies: Immunology, Digital Pathology and Metabolomics
- FUSION Technology
2015 – 2018
- Clinical data management for biomarker research
- Innovative use of information for clinical care and biomarker research
- Knowledge discovery and advanced interactive data mining
- Next generation sequencing-based biomarkers in molecular pathology
- Metabolomics Platform for biomarker research
- Immunology Platform for biomarker research
- Health technology assessment
- Digital Pathology
- Clinical MALDI application
CANCER RESEARCH FOR PRECISION MEDICINE
As of 2019
- Liquid biopsy in cancer
- Translational molecular imaging agents for in-vitro and in-vivo application
- Next-generation drug-screening platform for precision oncology services
- Near-infrared light exposure in cancer
2015 – 2018
- Circulating tumour cells and cell-free nucleic acids as biomarkers for disease monitoring
- Tracking the trace: Detection, selection and target evaluation of cellular and cell-free cancer biomarkers
- Blood based, broad-spectrum biomarker panels for cancer diagnostics
- Minimal residual disease detection as a prognostic biomarker and therapeutic target in hematologic malignancies using monoclonal antibodies and development of therapeutic chimeric antibody receptor (CAR) T cells
- Genomic, transcriptomic and proteomic evaluation of eukaryotic initiation factors (eIFs) in various tumour entities
- Galpha12 and Galpha13 as prognostic biomarkers and inducers of apoptosis in solid cancers
- MR-PDX-models for the evaluation of cancer treatments
- Core Lab for target identification and in-vivo probe development
- Fusion Technology: Colon Cancer Stage 2
MICROBIOME RESEARCH FOR PRECISION MEDICINE
As of 2019
- Biomarkers for cardiometabolic health and disease
- Biomarkers in acute cardio-reno-metabolic disease states
- Diagnostic and predictive biomarkers in disorders of fertility and metabolism
- Microbiome-based biomarkers
2015 – 2018
- Biomarkers to address diabesity
- Biomarkers in early detection and risk assessment of cardiovascular disease
- Biosensors for short-lived biomarkers
- Biomarkers of bone metabolism and related organ systems
- Biomarkers in the regulation of fertility
- Minimally-invasive biomarkers for liver function
- In-vivo biomarkers for inflammation and fibrosis diagnosis and therapy monitoring
- Minimally-invasive broad spectrum biomarkers for NAFLD diagnosis and monitoring
- Biomarkers for probiotic effects on microbiome-gut-brain axis
- Biomarkers for early sepsis detection
- Molecular signatures as biomarkers of invasive fungal infections
- Electrochemical biomarkers‚ detection in common metabolic disorders